PRVA Privia Health Group, Inc. Common Stock
XNAS
22.47
Delayed
Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Expected move IV rank history Fibonacci levels Insider trading
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
- 52-Week Range
- $18.91 – $28.82
- YTD
- -4.22%
- IV Rank (30D)
- 100.0
- Straddle Price
- $3.90
- P/C Vol Ratio
- 0.01
- Market Cap
- $2.9B
- Open
- $22.88
- Day Range
- $22.44 – $23.13
- Volume
- 1,021,810
- Prev Close
- $22.93
A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.
- DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
- Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
- DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 2% and dividend payments are stable — below that the dividend is a token payout and Gordon (which values only the dividend stream) systematically underprices growth names, so those route to DCF + comparables + market anchor instead.
- P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
- Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
- Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
- Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
- Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
| 10-yr Treasury (rf) | 5.15% |
| Beta vs SPY | 0.79 |
| Cost of Equity (CAPM) | 9.10% (VRP-adj) |
| WACC | 9.16% |
| Volatility Risk Premium | +76.3pp (IV − HV30) |
| Effective Tax Rate | 39.7% |
| Rev. Growth (YoY, DCF input) | +9.0% |
| DCF Horizon | 10 years explicit + fade |
| Forward Tilt (NTM/TTM) | ×1.09 (applied to P/E, EV/EBITDA, P/S) |
| Free Cash Flow (TTM) | $0.1B |
| Return on Equity (TTM) | 3.6% |
| Book / Price | 28.7% |
| Gross Margin (TTM) | 88.7% |
| FCF Margin (TTM) | 5.6% |
| Debt / Equity | 0.00 |
| Quality Score | 2/6 — normal (10y DCF) |
| Market-Implied Growth | +6.2% (reverse-DCF on current price) |
| SMA 50 | $20.81 (Market Anchor value) |
| SMA 20 / Bollinger Mid | $20.92 |
| Bollinger Width / SMA20 | 105.0% (drives anchor stability) |
| Net Debt | $-0.4B |
| Market Cap | $3B |
| Method | Implied Price | Weight | Detail |
|---|---|---|---|
| DCF | $25.89 | 35% | |
| DDM (Gordon) | n/a | 0% | |
| Peer P/E | $5.61 | 8% | median 24.5× · 6 peers |
| Peer EV/EBITDA | $265.46 | 10% | median 16.4× · 6 peers |
| Peer P/B | $49.86 | 14% | median 7.7× · 8 peers |
| Peer P/S | $92.36 | 14% | median 4.7× · 8 peers |
| Market Anchor (SMA50) | $20.81 | 0% | stability 0% (BB-width) |
| Options Expected (B-L 30d) | $22.10 | 19% | 11 strikes · skew -0.76 |

- Industry (SIC)
- SERVICES-HEALTH SERVICES (8000) · industry map
- Exchange
- XNAS
- Market Cap
- $2.9B
- Employees
- 1,226
- List Date
- 2021-04-29
- CIK
- 0001759655
- Next Earnings
- 2026-11-05 (Pre-Market)
- EPS Forecast
- $0.09 (4 est.)
- Headquarters
- Arlington, VA
- Homepage
- https://www.priviahealth.com
Privia Health Group Inc is one of the physician enablement companies in the United States with a presence in around 24 states and the District of Columbia. The group builds scaled provider networks with primary-care centric medical groups, risk-bearing entities, a physician-led governance structure, and the Privia Platform comprising an extensive suite of technology and service solutions. It collaborates with medical groups, health plans, and health systems to optimize approximately 1,300+ physician practices, improve the patient experience for over 5.8+ million patients, and reward around 5,3…
Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.
| Month | '21 | '22 | '23 | '24 | '25 | '26 | Avg |
|---|---|---|---|---|---|---|---|
| Jan | -- | -21.13% | 21.31% | -14.97% | 16.34% | -1.02% | 0.11% |
| Feb | -- | 19.50% | 1.16% | 8.72% | 9.04% | 1.45% | 7.97% |
| Mar | -- | 4.74% | -2.23% | -12.23% | -10.06% | -14.43% | -6.84% |
| Apr | 4.52% | -19.77% | -0.54% | -3.21% | 2.62% | 17.94% | 0.26% |
| May | -8.14% | 4.17% | -10.83% | -3.66% | -0.61% | -13.44% | -5.42% |
| Jun | 32.84% | 26.83% | 7.14% | 0.29% | 0.74% | 20.74% | 14.76% |
| Jul | -4.16% | 27.27% | 9.06% | 21.29% | -13.40% | -11.94% | 4.69% |
| Aug | -28.32% | 8.07% | -5.23% | -1.76% | 22.16% | -13.87% | -3.16% |
| Sep | -19.70% | -14.21% | -12.51% | -5.60% | 7.37% | -4.60% | -8.21% |
| Oct | 11.35% | -3.26% | -6.62% | 4.56% | -2.72% | 12.18%* | 2.58% |
| Nov | -10.57% | -26.80% | 1.18% | 13.11% | -1.58% | -- | -4.93% |
| Dec | 15.91% | -6.04% | 5.64% | -12.37% | -1.62% | -- | 0.30% |
| Total | -18.79% | -17.85% | 2.90% | -11.54% | 25.43% | -14.03% | -5.65% |
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
Momentum Oscillators
Volume & Volatility
Data Summary
LLM Stock Analysis Report
Executive Summary
Overall assessment: NEUTRAL (6/10)
Key drivers:
- Technical indicators suggest a neutral trend, with short-term momentum signals weakening
- Volatility is low, indicating reduced market uncertainty
- Recent earnings history has been stable, with no major surprises or disappointments
Primary risks:
- Options market suggests a potential move higher, but volatility remains subdued
- Earnings history could influence future stock performance, particularly if there are any significant changes to revenue or profitability
Investment thesis:
PRVA is likely to consolidate around current levels, with limited upside or downside potential. The stock's neutral trend and low volatility suggest that investors may want to wait for clearer signals before making a move.
Recent news sentiment impact:
No recent news headlines available; therefore, no impact on the analysis.
Technical Analysis
Trend Direction: NEUTRAL (short-term)
- SMA 20: $24.05
- SMA 50: $24.35
- SMA 200: $23.00
Support/Resistance Levels:
- Upper Bollinger Band: $24.75
- Middle Bollinger Band: $24.05
- Lower Bollinger Band: $23.36
Momentum Signals:
- RSI (14): 51.36 (neutral)
- MACD: -0.05 / Signal: -0.02 / Histogram: -0.04 (bearish)
Volume Analysis:
- Volume SMA 20: 667028.00
- On-Balance Volume (OBV): -1727971.00
- Volume Rate of Change: -44.06%
News & Sentiment Analysis
Recent Headlines Summary: No recent news headlines available.
Sentiment Assessment: NEUTRAL
Catalyst Identification: None identified.
Market Narrative: The lack of recent news headlines suggests a neutral market narrative, with no significant events or surprises influencing the stock's price movement.
Risk & Volatility Assessment
Beta Interpretation:
- Beta: 0.55 (vs SPY)
- Low volatility - stock moves less than market
Volatility Regime:
- Stock Volatility: 0.32
- Low volatility regime, indicating reduced market uncertainty
Options Market Signals:
- IV Rank: 6.2% (Low)
- Current IV: 53.0%
- Expected Move: $2.08 (21 DTE), 7-DTE: $2.08
- Volume Flow: 11 calls vs 1 puts
- Open Interest: 12 calls vs 1 puts
- Put/Call Volume Ratio: 0.09 (Bullish sentiment)
- Put/Call OI Ratio: 0.08
Downside Protection:
- Support levels: $23.36, $22.50
- Risk management considerations: Stop-loss at $23.30, position sizing considering volatility
Market Context & Positioning
Sector Performance:
- PRVA is outperforming the broader market (SPY)
Institutional Activity:
- Volume patterns suggesting institutional interest in buying
Correlation Analysis:
- R-squared interpretation: 0.34 (low correlation with SPY)
Relative Valuation:
- Position within trading range: Neutral, considering recent price action and volatility
Key Levels & Action Items
Critical Price Levels:
- $24.75 (upper Bollinger Band)
- $23.36 (lower Bollinger Band)
Breakout/Breakdown Levels:
- None identified.
Time-Sensitive Catalysts:
- Earnings date: 2025-11-06
Risk Management:
- Stop-loss at $23.30
- Position sizing considering volatility and recent price action
Please note that this analysis is based on the provided data, and you should consider additional factors before making any investment decisions.
| Earnings Date | Timing | Expected Move | Actual Move | Ratio | Outcome |
|---|---|---|---|---|---|
| 2021-11-08 | Pre-Market | 23.84% | 14.31% | 0.60x | Within |
| 2022-08-11 | Pre-Market | 12.63% | 3.98% | 0.32x | Within |
| 2022-11-10 | Pre-Market | 9.61% | 11.93% | 1.24x | Exceeded |
| 2023-02-28 | Pre-Market | 12.22% | 3.44% | 0.28x | Within |
| 2023-05-04 | Pre-Market | 10.92% | 1.22% | 0.11x | Within |
| 2023-08-03 | Pre-Market | 11.89% | 1.67% | 0.14x | Within |
| 2023-11-03 | Pre-Market | 13.13% | 14.34% | 1.09x | Exceeded |
| 2024-02-27 | Pre-Market | 12.90% | 9.75% | 0.76x | Within |
| 2024-05-09 | Pre-Market | 9.86% | 4.40% | 0.45x | Within |
| 2024-08-08 | After-Close | 11.89% | 1.45% | 0.12x | Within |
| 2024-11-07 | After-Close | 12.43% | 5.46% | 0.44x | Within |
| 2025-02-27 | Pre-Market | 10.81% | 5.82% | 0.54x | Within |
| 2025-05-08 | Pre-Market | 12.01% | 7.50% | 0.62x | Within |
| 2025-08-07 | Pre-Market | 8.97% | 1.37% | 0.15x | Within |
| 2025-11-06 | Pre-Market | 9.69% | 4.16% | 0.43x | Within |
| 2026-02-26 | Pre-Market | 12.58% | 9.98% | 0.79x | Within |
| 2026-05-07 | Pre-Market | 10.94% | 0.00% | 0.00x | Within |
| 2026-08-06 | Pre-Market | 11.37% | 8.18% | 0.72x | Within |
Earnings calendar: this week’s reports with expected vs actual moves →
PRVA Options Activity & IV Rank
PRVA IV rank history, 52-week IV rank and IV percentile →
Volatility Metrics
Options Flow
ATM Options Pricing
Chain Summary
Each spread is ranked by a composite score built in three stages. Full documentation →
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Enter a ticker to scan for optimal spread opportunities.
Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.
Estimated net dealer gamma is at the 69th percentile of this name's own daily history, within its typical range. This describes current positioning; it is not a forecast or a trading signal.
Net dealer gamma is an estimate of the aggregate gamma held by options market makers across this name's option chain, weighted by open interest. Dealer positions aren't public, so it uses a standard simplifying assumption: dealers are treated as long the calls and short the puts that are open. Actual dealer books can differ.
Gamma percentile ranks today's estimate against this name's own daily history, from 0% (the lowest reading on record) to 100% (the highest). Raw gamma scales with how much open interest a chain carries, so it isn't comparable across names; the percentile is. The badge marks the bottom 20% as low and the top 20% as high.
Tilts run from −1 to +1 and show how lopsided the estimated dealer exposure is. GEX tilt compares call gamma with put gamma. Vanna tilt describes how the hedge would shift if implied volatility changed, and charm tilt how it would shift with the passage of time.
This card describes estimated positioning and where it sits historically. It is not a forecast of price direction or volatility and not a trading signal. Market-wide view: Dealer positioning screener.
IV(put wing) − IV(ATM), in vol pointsHow much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.
- Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
- Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
- Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
- Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
IV(call wing) − IV(put wing), equal delta on each sideWhich side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.
- Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
- Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
- Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
- Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:
- High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
- Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
- Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.
Enter a ticker to render the implied volatility surface.
Enter a ticker to render the implied volatility smile.
Risk Metrics
Analysis Details
Data Points: 251
Period: 252 trading days
Low volatility - stock moves less than market
| Investor | Value | Share of their portfolio | Rank | Q/Q shares | Source |
|---|---|---|---|---|---|
| Renaissance Technologies Hedge fund Jim Simons | $16.3M | #804 of 3138 | -18.5% | 13F | |
| Millennium Management Hedge fund Izzy Englander | $6.9M | #1839 of 3716 | -62.3% | 13F | |
| Citadel Hedge fund Ken Griffin | $1.3M | #3432 of 6285 | -90.0% | 13F | |
| Rockefeller Capital Management Family office Rockefeller family | $2K | #4376 of 4729 | -19.8% | 13F |
Hedge funds, activists, holding companies and family offices we track, from their latest 13F (quarter-end value) and Form 4 filings in the last 3 years. Family offices · all institutions
PRVA Institutional Ownership (13F)
Latest filings — 2026-09-30Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.
- Shares — long equity positions in this name, aggregated across share classes.
- Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
- % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
- Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.
Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | Jane Street Group, LLC Custodian | $1.89M | 35.27% | 2026-06-30 |
| 2 | Susquehanna International Group, LLP Custodian | $1.60M | 29.89% | 2026-06-30 |
| 3 | Citadel Advisors LLC Custodian | $728.16K | 13.60% | 2026-06-30 |
| 4 | Simplex Trading, LLC Custodian | $439.98K | 8.22% | 2026-06-30 |
| 5 | Wolverine Trading, LLC Custodian | $429.79K | 8.03% | 2025-09-30 |
| 6 | IMC-Chicago, LLC Custodian | $267.59K | 5.00% | 2026-06-30 |
| # | Filer | Notional Value | % of Total | Period |
|---|
PRVA Insider Trading (Form 4)
Latest: 2026-09-03| Filed | Reporter | Role | Action | Shares | Avg Price | Net $ | Link |
|---|---|---|---|---|---|---|---|
| 2026-09-03 | Opella Finley Ernest | Director | Award (A) | +6,350 | — | EDGAR | |
| 2026-07-13 | David Mountcastle | EVP & Chief Financial Officer | Sell (S) | −21,275 | $27.67 | -$588.7K | EDGAR |
| 2026-07-09 | David Mountcastle | EVP & Chief Financial Officer | Sell (S) | −600 | $27.57 | -$16.5K | EDGAR |
| 2026-07-07 | David Mountcastle | EVP & Chief Financial Officer | Sell (S) | −24,734 | $27.50 | -$680.2K | EDGAR |
| 2026-07-07 | Matthew Shawn Morris | Director | Mixed | — | $14.64 | -$2.85M | EDGAR |
| 2026-07-02 | Matthew Shawn Morris | Director | Mixed | — | $14.16 | -$3.30M | EDGAR |
| 2026-05-22 | Jaewon Ryu | Director | Award (A) | +8,463 | — | EDGAR | |
| 2026-05-22 | Nancy G Cocozza | Director | Award (A) | +8,463 | — | EDGAR | |
| 2026-05-22 | Lance Berberian | Director | Award (A) | +8,463 | — | EDGAR | |
| 2026-05-22 | Thomas A McCarthy | Director | Award (A) | +8,463 | — | EDGAR | |
| 2026-05-22 | David P King | Director | Award (A) | +8,463 | — | EDGAR | |
| 2026-05-22 | Francis S Soistman Jr | Director | Award (A) | +8,463 | — | EDGAR | |
| 2026-05-22 | Matthew Shawn Morris | Director | Award (A) | +8,463 | — | EDGAR | |
| 2026-05-22 | Pamela O Kimmet | Director | Award (A) | +8,463 | — | EDGAR | |
| 2026-05-13 | Parth Mehrotra | Chief Executive Officer | Sell (S) | −121,086 | $22.56 | -$2.73M | EDGAR |
PRVA Insider Holdings
14 insiders · @ $22.47| # | Insider | Role | Shares | Disclosed Exposure | Lifetime OM Net | Filings | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | David S Wichmann | Director | 1,341,049 | $30.13M | $0 | 3 | 2025-05-23 |
| 2 | Parth Mehrotra | Chief Executive Officer | 583,475 | $13.11M | -$98.74M | 55 | 2026-05-13 |
| 3 | David Mountcastle | EVP & Chief Financial Officer | 173,548 | $3.90M | -$12.31M | 40 | 2026-07-13 |
| 4 | Matthew Shawn Morris | Director | 142,860 | $3.21M | -$68.16M | 31 | 2026-07-07 |
| 5 | Edward C Fargis | EVP & General Counsel | 111,979 | $2.52M | -$335.0K | 6 | 2026-03-12 |
| 6 | Thomas A McCarthy | Director | 69,470 | $1.56M | $163.7K | 8 | 2026-05-22 |
| 7 | David P King | Director | 50,775 | $1.14M | $0 | 6 | 2026-05-22 |
| 8 | Jaewon Ryu | Director | 47,110 | $1.06M | $0 | 6 | 2026-05-22 |
| 9 | Nancy G Cocozza | Director | 42,814 | $962.0K | $0 | 5 | 2026-05-22 |
| 10 | Patricia Anne Maryland | Director | 42,312 | $950.8K | $0 | 5 | 2025-05-23 |
PRVA Board & Officers
As of SEC filings through Sep 3, 2026Directors 11
- David P King · since Apr 28, 2021
- Patricia Anne Maryland · since Apr 28, 2021
- Thomas A McCarthy · since Apr 28, 2021
- Jaewon Ryu · since Jun 30, 2021
- Nancy G Cocozza · since Apr 1, 2022
- Parth Mehrotra · listed since Jul 2023
- David S Wichmann · since Aug 1, 2023
- Pamela O Kimmet · since Aug 1, 2023
- Lance Berberian · since Jul 15, 2025
- Francis S Soistman Jr · since May 20, 2026
- Opella Finley Ernest · since Sep 1, 2026
Officers 3
- Parth Mehrotra · Chief Executive Officer · listed since Jul 2023
- David Mountcastle · EVP & Chief Financial Officer · listed since Apr 2022
- Edward C Fargis · EVP & General Counsel · since Jan 29, 2024
Changes in the last 10 years (77)
| Sep 1, 2026 | Opella Finley Ernest became a director |
| Jul 7, 2026 | Matthew Shawn Morris reported in an SEC filing no longer being a director |
| May 20, 2026 | Francis S Soistman Jr became a director |
| Jul 15, 2025 | Lance Berberian became a director |
| Jul 1, 2024 | The company announced the departure of William M Sullivan from the board in an SEC filing |
| May 2, 2024 | Thomas Bartrum reported in an SEC filing no longer being EVP, General Counsel |
| Jan 29, 2024 | Edward C Fargis became EVP & General Counsel |
| Aug 1, 2023 | Pamela O Kimmet became a director |
| Aug 1, 2023 | David S Wichmann became a director |
| Jul 31, 2023 | The company announced the departure of Jeffrey Daniel Bernstein from the board in an SEC filing |
| Jul 21, 2023 | Parth Mehrotra listed as Chief Executive Officer (previously President and COO) in SEC filings |
| Jul 21, 2023 | Parth Mehrotra first listed as a director in an SEC filing |
| Jul 1, 2023 | Adam Boehler became a director |
| May 11, 2023 | Pamplona Private Equity Carryco III, L.P. reported in an SEC filing no longer being a 10% owner |
| May 11, 2023 | Pamplona PE Investments Malta Ltd reported in an SEC filing no longer being a 10% owner |
| May 11, 2023 | Pamplona PE Investments II, Ltd. reported in an SEC filing no longer being a 10% owner |
| May 11, 2023 | Pamplona Equity Carryco Advisors III, Ltd. reported in an SEC filing no longer being a 10% owner |
| May 11, 2023 | Pamplona Equity Advisors III Ltd reported in an SEC filing no longer being a 10% owner |
| May 11, 2023 | Pamplona Capital Partners III, L.P. reported in an SEC filing no longer being a 10% owner |
| May 11, 2023 | Pamplona Capital Management, LLP reported in an SEC filing no longer being a 10% owner |
| May 11, 2023 | Pamplona Capital Management, LLC reported in an SEC filing no longer being a 10% owner |
| May 11, 2023 | John C. Halsted reported in an SEC filing no longer being a 10% owner |
| May 11, 2023 | Alexander M Knaster reported in an SEC filing no longer being a 10% owner |
| May 10, 2023 | Mbd 2013, L.p. reported in an SEC filing no longer being a 10% owner |
| May 10, 2023 | MBD Advisors, L.L.C. reported in an SEC filing no longer being a 10% owner |
| May 10, 2023 | MBD 2013 Offshore, L.P. reported in an SEC filing no longer being a 10% owner |
| May 10, 2023 | MBD 2013 Holdings, L.P. reported in an SEC filing no longer being a 10% owner |
| May 10, 2023 | Goldman Sachs Group Inc reported in an SEC filing no longer being a 10% owner |
| May 10, 2023 | Goldman Sachs & Co. LLC reported in an SEC filing no longer being a 10% owner |
| May 10, 2023 | Broad Street Principal Investments, L.L.C. reported in an SEC filing no longer being a 10% owner |
| May 10, 2023 | Bridge Street Opportunity Advisors, L.L.C. reported in an SEC filing no longer being a 10% owner |
| May 10, 2023 | Bridge Street 2013, L.P. reported in an SEC filing no longer being a 10% owner |
| May 10, 2023 | Bridge Street 2013 Offshore, L.P. reported in an SEC filing no longer being a 10% owner |
| May 10, 2023 | Bridge Street 2013 Holdings, L.P. reported in an SEC filing no longer being a 10% owner |
| Apr 7, 2023 | The company announced the departure of Matthew Shawn Morris as Chief Executive Officer in an SEC filing |
| Nov 15, 2022 | Jeffrey B Butler reported in an SEC filing no longer being a director |
| Apr 6, 2022 | Pamplona Private Equity Carryco III, L.P. first on file as a 10% owner |
| Apr 6, 2022 | Pamplona Equity Carryco Advisors III, Ltd. first on file as a 10% owner |
| Apr 1, 2022 | Nancy G Cocozza became a director |
| Apr 1, 2022 | David Mountcastle first listed as EVP & Chief Financial Officer in an SEC filing |
| Mar 16, 2022 | The company announced the departure of Jeffrey Scott Sherman as EVP, CFO and CAO in an SEC filing |
| Jan 7, 2022 | David Mountcastle reported in an SEC filing no longer being Chief Financial Officer |
| Jan 5, 2022 | Jeffrey Scott Sherman became EVP, CFO and CAO |
| Jun 30, 2021 | Jaewon Ryu became a director |
| Apr 28, 2021 | William Sherrill became a director |
| Apr 28, 2021 | William M Sullivan became a director |
| Apr 28, 2021 | Thomas Bartrum became EVP, General Counsel |
| Apr 28, 2021 | Thomas A McCarthy became a director |
| Apr 28, 2021 | Patricia Anne Maryland became a director |
| Apr 28, 2021 | Parth Mehrotra became President and COO |
| Apr 28, 2021 | Pamplona PE Investments Malta Ltd became a 10% owner |
| Apr 28, 2021 | Pamplona PE Investments II, Ltd. became a 10% owner |
| Apr 28, 2021 | Pamplona Equity Advisors III Ltd became a 10% owner |
| Apr 28, 2021 | Pamplona Capital Partners III, L.P. became a 10% owner |
| Apr 28, 2021 | Pamplona Capital Management, LLP became a 10% owner |
| Apr 28, 2021 | Pamplona Capital Management, LLC became a 10% owner |
| Apr 28, 2021 | Pamplona Capital Management (Monaco) SAM became a 10% owner |
| Apr 28, 2021 | Mbd 2013, L.p. became a 10% owner |
| Apr 28, 2021 | Matthew Shawn Morris became a director |
| Apr 28, 2021 | Matthew Shawn Morris became Chief Executive Officer |
| Apr 28, 2021 | MBD Advisors, L.L.C. became a 10% owner |
| Apr 28, 2021 | MBD 2013 Offshore, L.P. became a 10% owner |
| Apr 28, 2021 | MBD 2013 Holdings, L.P. became a 10% owner |
| Apr 28, 2021 | John C. Halsted became a 10% owner |
| Apr 28, 2021 | Jeffrey Daniel Bernstein became a director |
| Apr 28, 2021 | Jeffrey B Butler became a director |
| Apr 28, 2021 | Goldman Sachs Group Inc became a 10% owner |
| Apr 28, 2021 | Goldman Sachs & Co. LLC became a 10% owner |
| Apr 28, 2021 | David P King became a director |
| Apr 28, 2021 | David Mountcastle became Chief Financial Officer |
| Apr 28, 2021 | Broad Street Principal Investments, L.L.C. became a 10% owner |
| Apr 28, 2021 | Brighton Health Group Holdings, LLC became a 10% owner |
| Apr 28, 2021 | Bridge Street Opportunity Advisors, L.L.C. became a 10% owner |
| Apr 28, 2021 | Bridge Street 2013, L.P. became a 10% owner |
| Apr 28, 2021 | Bridge Street 2013 Offshore, L.P. became a 10% owner |
| Apr 28, 2021 | Bridge Street 2013 Holdings, L.P. became a 10% owner |
| Apr 28, 2021 | Alexander M Knaster became a 10% owner |
- Prev
- 1
Not reported recently (4)
- Adam Boehler · Last reported as a director in an SEC filing dated Jun 13, 2024
- William Sherrill · Last reported as a director in an SEC filing dated May 11, 2022
- Pamplona Capital Management (Monaco) SAM · Last reported as a 10% owner in an SEC filing dated Apr 29, 2022
- Brighton Health Group Holdings, LLC · Last reported as a 10% owner in an SEC filing dated May 14, 2021
PRVA Proposed Insider Sales (Form 144)
Latest: 2026-07-09What is Form 144? A notice of intent to sell restricted or control stock under Rule 144. Affiliates (officers, directors, 10%+ owners) and holders of restricted shares must file Form 144 when planning to sell more than 5,000 shares or $50,000 in any 3-month rolling window.
How it relates to Form 4: Form 144 is filed before the trade (up to 90 days in advance); Form 4 is filed within 2 business days after the trade executes. Not every Form 144 results in a sale — the filer may cancel or delay. Look for the corresponding Form 4 on the Insider Activity card to confirm a sale actually happened.
10b5-1 plans: Trades made under a pre-scheduled Rule 10b5-1 plan are not discretionary — they execute automatically on dates set months earlier, regardless of news. High 10b5-1 percentages mean less per-filing signal value, though cumulative selling volume still matters.
"Notice value": Aggregate market value the filer wrote into the Form 144 — i.e. the size of the planned sale, not necessarily the executed dollars. An amended notice (Form 144/A) replaces the original it amends, and cancelled notices are dropped, so neither is double-counted above. A filed value that is clearly inconsistent with the share count at the stock's price (a filer typo) shows as a dash and is left out of the totals.
Source & freshness: Sourced from public Form 144 filings. Refreshed daily; new filings typically appear here the morning after they are filed.
| Filed | Filer | Role | Shares | Notice Value | Planned Sale | Broker | Plan | Link |
|---|---|---|---|---|---|---|---|---|
| 2026-07-09 | Mountcastle David | Officer | 21,275 | $588.6K | 2026-07-09 | Fidelity Brokerage Services LLC | 10b5-1 | EDGAR |
| 2026-07-07 | Mountcastle David | Officer | 600 | $16.5K | 2026-07-07 | Fidelity Brokerage Services LLC | 10b5-1 | EDGAR |
| 2026-07-02 | Mountcastle David | Officer | 24,734 | $680.2K | 2026-07-02 | Fidelity Brokerage Services LLC | 10b5-1 | EDGAR |
| 2026-06-26 | Mountcastle David | Officer | 17,196 | $433.0K | 2026-06-26 | Fidelity Brokerage Services LLC | 10b5-1 | EDGAR |
| 2026-05-12 | Mehrotra Parth | Officer, Director | 15,647 | $354.2K | 2026-05-12 | Fidelity Brokerage Services LLC | 10b5-1 | EDGAR |
| 2026-05-11 | Mehrotra Parth | Officer, Director | 91,403 | $2.06M | 2026-05-11 | Fidelity Brokerage Services LLC | 10b5-1 | EDGAR |
| 2026-05-11 | Mountcastle David | Officer | 3,385 | $76.5K | 2026-05-11 | Fidelity Brokerage Services LLC | — | EDGAR |
| 2026-05-11 | Mehrotra Parth | Officer, Director | 14,036 | $317.3K | 2026-05-11 | Fidelity Brokerage Services LLC | — | EDGAR |
| 2026-05-04 | Mountcastle David | Officer | 1,206 | $30.1K | 2026-05-04 | Fidelity Brokerage Services LLC | 10b5-1 | EDGAR |
| 2026-05-01 | Mountcastle David | Officer | 7,179 | $179.7K | 2026-05-01 | Fidelity Brokerage Services LLC | 10b5-1 | EDGAR |
| # | ETF | Provider | Weight | $ Exposure | ETF AUM | As Of |
|---|---|---|---|---|---|---|
| 1 | IJR iShares Core S&P Small-Cap ETF | iShares (BlackRock) | 0.17% | $174.4M | $103.1B | 2026-10-20 |
| 2 | VTI Vanguard Morningstar Total Stock Market ETF | Vanguard | 0.00% | $76.7M | — | 2026-09-30 |
| 3 | IWM iShares Russell 2000 ETF | iShares (BlackRock) | 0.09% | $69.9M | $75.1B | 2026-10-20 |
| 4 | VB Vanguard Morningstar Small-Cap ETF | Vanguard | 0.03% | $53.8M | — | 2026-09-30 |
| 5 | VBK Vanguard Morningstar Small-Cap Growth ETF | Vanguard | 0.07% | $30.0M | — | 2026-09-30 |
| 6 | VXF Vanguard Extended Market ETF | Vanguard | 0.03% | $28.2M | — | 2026-09-30 |
| 7 | IJT iShares S&P Small-Cap 600 Growth ETF | iShares (BlackRock) | 0.36% | $27.0M | $7.6B | 2026-10-20 |
| 8 | SPSM State Street® SPDR® Portfolio S&P 600™ Small Cap ETF | SPDR (State Street) | 0.17% | $26.6M | $15.7B | 2026-10-20 |
| 9 | IWO iShares Russell 2000 Growth ETF | iShares (BlackRock) | 0.19% | $25.5M | $13.6B | 2026-10-20 |
| 10 | DFAS Dimensional US Small Cap ETF | Dimensional | 0.06% | $21.5M | — | 2026-10-20 |
| 11 | FESM Fidelity Enhanced Small Cap Core ETF | Fidelity | 0.26% | $17.1M | $6.6B | 2026-10-20 |
| 12 | SLYG State Street® SPDR® S&P 600™ Small Cap Growth ETF | SPDR (State Street) | 0.36% | $16.7M | $4.6B | 2026-10-20 |
| 13 | VTWO Vanguard Russell 2000 ETF | Vanguard | 0.08% | $13.8M | — | 2026-09-30 |
| 14 | SCHA Schwab U.S. Small-Cap ETF | Nport | 0.05% | $11.9M | — | 2026-05-31 |
| 15 | DFAC Dimensional US Core Equity 2 ETF | Dimensional | 0.01% | $10.2M | — | 2026-10-20 |
| 16 | DFMC Dimensional US Micro Cap ETF | Dimensional | 0.12% | $9.4M | — | 2026-10-20 |
| 17 | VIOO Vanguard S&P Small-Cap 600 ETF | Vanguard | 0.15% | $8.9M | — | 2026-09-30 |
| 18 | VHT Vanguard Health Care ETF | Vanguard | 0.03% | $5.9M | — | 2026-09-30 |
| 19 | IHF iShares U.S. Healthcare Providers ETF | iShares (BlackRock) | 0.36% | $4.9M | $1.4B | 2026-10-20 |
| 20 | XHS State Street® SPDR® S&P® Health Care Services ETF | SPDR (State Street) | 1.89% | $4.2M | $221.4M | 2026-10-20 |
| 21 | ITOT iShares Core S&P Total U.S. Stock Market ETF | iShares (BlackRock) | 0.00% | $3.9M | $97.4B | 2026-10-20 |
| 22 | VIOG Vanguard S&P Small-Cap 600 Growth ETF | Vanguard | 0.36% | $3.6M | — | 2026-10-20 |
| 23 | FNDA Schwab Fundamental U.S. Small Company ETF | Nport | 0.04% | $3.6M | — | 2026-05-31 |
| 24 | RWJ Invesco S&P SmallCap 600 Revenue ETF | Invesco | 0.17% | $3.4M | — | 2026-10-20 |
| 25 | DCOR Dimensional US Core Equity 1 ETF | Dimensional | 0.01% | $3.3M | — | 2026-10-20 |
Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.
- Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
- Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
- Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
- Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
- Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
- YoY growth — compare to the same quarter a year earlier to remove seasonality.
- Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
- Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.
TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.
Quarterly figures (12 quarters)
| Quarter | Period End | Revenue | Net Income | Diluted EPS | Op. Cash Flow |
|---|---|---|---|---|---|
| Q2 '26 | 2026-06-30 | $632.63M | $9.05M | $0.07 | $1.10M |
| Q1 '26 | 2026-03-31 | $603.85M | $3.06M | $0.02 | $-49.47M |
| Q4 '25 | 2025-12-31 | $541.17M | $9.15M | $0.07 | $127.50M |
| Q3 '25 | 2025-09-30 | $580.42M | $6.86M | $0.05 | $51.99M |
| Q2 '25 | 2025-06-30 | $521.15M | $2.69M | $0.02 | $7.97M |
| Q1 '25 | 2025-03-31 | $480.10M | $4.22M | $0.03 | $-24.06M |
| Q4 '24 | 2024-12-31 | $460.90M | $4.40M | $0.03 | $74.80M |
| Q3 '24 | 2024-09-30 | $437.92M | $3.54M | $0.03 | $33.15M |
| Q2 '24 | 2024-06-30 | $422.33M | $3.47M | $0.03 | $34.47M |
| Q1 '24 | 2024-03-31 | $415.24M | $2.98M | $0.02 | $-33.14M |
| Q4 '23 | 2023-12-31 | $440.83M | $2.84M | $0.03 | $64.10M |
| Q3 '23 | 2023-09-30 | $417.28M | $5.64M | $0.05 | $22.46M |
Ratios derived from TTM financials and the current market price, sampled daily. History chart shows how expensive the stock is today relative to its own recent past.
- P/E — price / TTM earnings. Rough market rule: 10–15 value, 15–25 market, >30 growth/premium. Negative when earnings are negative.
- P/B — price / book value. Useful for financials and asset-heavy names; meaningless for asset-light software.
- P/S — price / TTM revenue. Useful when earnings are negative or noisy (early-stage growth).
- EV/EBITDA — capital-structure-neutral. <10 cheap, 10–15 reasonable, >20 rich. Good for comparing across leverage profiles.
- EV/Sales — like P/S but accounts for debt + cash. Compare within sector.
- ROE — return on equity. >15% strong, >25% exceptional. Caution: high leverage inflates ROE.
- ROA — return on assets. Leverage-neutral; >5% solid, >10% exceptional.
- Div Yield — annual dividend / price. Compare to 10Y Treasury; sustained yield >6% often signals distress.
- FCF Yield — free cash flow / market cap. >5% is attractive; negative means burning cash.
- Debt/Equity — leverage. <1 conservative, >2 aggressive. Sector-dependent (utilities naturally high, tech low).
- Current Ratio — short-term liquidity. >1.5 comfortable, <1 raises short-term solvency flags.
- Compare current level to the 3-year band: near the high end = relatively expensive; near the low = relatively cheap.
- Multiples expanding while earnings are flat = sentiment-driven rally.
- Multiples compressing while earnings grow = value coming from fundamentals.
Regulatory short-interest reports publish on a bi-weekly settlement cadence; short-volume is reported daily by the trade-reporting facilities. Float is derived from insider-ownership filings.
- Short Interest — total shares currently sold short as of the settlement date. Lags real time by ~8 business days.
- SI % of Float — short interest / free float. The key crowding metric.
- Days to Cover — short interest / avg daily volume. How many full trading days it would take shorts to buy back. High DTC + catalyst = squeeze fuel.
- Short Vol Ratio — today's short-sale volume / total volume. Intraday selling pressure proxy (not the same as short interest).
- Free Float — shares available for public trading (total shares minus insider / restricted).
- Float % — free float / shares outstanding. <50% = tightly held, more prone to squeezes.
- SI % of Float < 5% — typical, no particular signal.
- 5–15% — elevated; watch for catalysts (earnings, guidance, macro).
- 15–30% — heavily shorted; tight-float names in this range have produced notable squeezes historically.
- >30% — extreme; borrow is likely expensive and squeeze risk is material.
- Days to Cover > 5 combined with high SI% amplifies squeeze potential.
- Trend matters more than level. Rapidly rising short interest often precedes negative catalysts or heavy hedging.
- A sudden drop in SI after a rally may indicate a squeeze in progress.
Short interest is reported mid-month and end-of-month; short volume is daily.